FindTrial
Sign In

Retrospective study on real-world clinical application, effect and safety of Keluoxin Capsule

Retrospective study on real-world clinical application, effect and safety of Keluoxin

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040999
Enrollment
Unknown
Registered
2020-12-16
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

case series:Nil

Sponsors

Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: For objective 1, the inclusion criteria: Patients who were prescribed Keluoxin caspule during Jan 2017 and Sep 2020.(including outpatient and inpatient patients). For objective 2,3, the inclusion criteria: 1.Patients who were diagnosed with diabetic kidney disease or diabete mellitus during Jan 2017 and Sep 2020.(including outpatient and inpatient patients); 2.Had at least one follow-up visit within 1 year after baseline visit.

Exclusion criteria

Exclusion criteria: 1.loss of baseline information(age,gender). 2.loss of prescription information(usage, dosage, course).

Design outcomes

Primary

MeasureTime frame
EGFR;ACR;ALT AST;Incidence of abdominal pain and diarrhea;medication cost;—

Countries

China

Contacts

Public ContactLu Hao

Shuguang Hospital affiliated with Shanghai University of TCM

luhao403@163.com+86 21-53847332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026